Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 718 - 724 (2002)
Published online: 17 June 2002; | doi:10.1038/nm723

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

Christian Grimm1, Andreas Wenzel1, 6, Matthias Groszer2, 6, Helmut Mayser3, Mathias Seeliger3, Marijana Samardzija1, Christian Bauer4, Max Gassmann4, 5, 6 & Charlotte E. Remé1, 6

1  Retinal Cell Biology, Department of Ophthalmology, University Hospital, Zurich, Switzerland

2  Howard Hughes Medical Institute, University of California Los Angeles, Los Angeles, California, USA

3  Retinal Electrodiagnostic Research Group, Department of Ophthalmology, University of Tuebingen, Tuebingen, Germany

4  Institute of Physiology, University of Zurich, Zurich, Switzerland

5  Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland

6  A.W. and M. Groszer as second authors, and M. Gassman and C.E.R. as senior authors contributed equally to this study.

Correspondence should be addressed to Christian Grimm cgrimm@opht.unizh.ch
Erythropoietin (Epo) is upregulated by hypoxia and provides protection against apoptosis of erythroid progenitors in bone marrow and brain neurons. Here we show in the adult mouse retina that acute hypoxia dose-dependently stimulates expression of Epo, fibroblast growth factor 2 and vascular endothelial growth factor via hypoxia-inducible factor-1alpha (HIF-1alpha) stabilization. Hypoxic preconditioning protects retinal morphology and function against light-induced apoptosis by interfering with caspase-1 activation, a downstream event in the intracellular death cascade. In contrast, induction of activator protein-1, an early event in the light-stressed retina, is not affected by hypoxia. The Epo receptor required for Epo signaling localizes to photoreceptor cells. The protective effect of hypoxic preconditioning is mimicked by systemically applied Epo that crosses the blood−retina barrier and prevents apoptosis even when given therapeutically after light insult. Application of Epo may, through the inhibition of apoptosis, be beneficial for the treatment of different forms of retinal disease.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

  • Postdoctoral Position

    • McGill University
    • Goodman Cancer Centre, McGill University, Cancer Pavilion, 1160 Pine Avenue West, Room 414, Montreal, Quebec , Canada, H3A 1A3
  • Postdoc in cancer research

    • Penn State University
    • Hershey, PA, USA 17033
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy